MICHAEL SERLIN: Open Payments
NPI 1568488336 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,316 in 16 payments from 6 companies in 2025. Trend: 2023 $5,069 · 2024 $1,079 · 2025 $6,316
Consulting: $6,026Food & beverage: $250Travel & lodging: $39
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 4 | $6,088 |
| Merck Sharp & Dohme LLC | 5 | $99 |
| Gilead Sciences, Inc. | 4 | $74 |
| Novo Nordisk Inc | 1 | $20 |
| Indivior Inc. | 1 | $20 |
| Braeburn Inc. | 1 | $15 |
Products named: PIFELTRO, APRETUDE, Ozempic, SUBLOCADE, Biktarvy, BRIXADI.
Industry payments across MD — which companies pay providers there.
